NEPHROGENEX INC - COM (NRXGQ)

CUSIP: 640667101

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COM
Total 13F shares
2,117,599
Share change
-79,531
Total reported value
$12,834,000
Price per share
$6.07
Number of holders
10
Value change
-$507,560
Number of buys
2
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 640667101?
CUSIP 640667101 identifies NRXGQ - NEPHROGENEX INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEPHROGENEX INC - COM (NRXGQ) as of Q2 2014

As of 30 Jun 2014, NEPHROGENEX INC - COM (NRXGQ) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,117,599 shares. The largest 10 holders included RHO CAPITAL PARTNERS INC, Visium Asset Management, LP, LMR Partners LLP, Knoll Capital Management, LP, BANK OF AMERICA CORP /DE/, First Western Capital Management Co, Revelation Capital Management Ltd., STONERIDGE INVESTMENT PARTNERS LLC, Tower Research Capital LLC, and BlackRock Investment Management, LLC. This page lists 10 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.